MeiraGTx Holdings plc

NASDAQ:MGTX

6.32 (USD) • At close February 4, 2025
Bedrijfsnaam MeiraGTx Holdings plc
Symbool MGTX
Munteenheid USD
Prijs 6.32
Beurswaarde 493,929,488
Dividendpercentage 0%
52-weken bereik 3.85 - 7.37
Industrie Biotechnology
Sector Healthcare
CEO Dr. Alexandria Forbes Ph.D.
Website https://www.meiragtx.com

An error occurred while fetching data.

Over MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis;

Vergelijkbare Aandelen

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

4.495 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

19.85 USD

Nyxoah S.A. logo

Nyxoah S.A.

NYXH

10.7 USD

Science 37 Holdings, Inc. logo

Science 37 Holdings, Inc.

SNCE

5.75 USD

RxSight, Inc. logo

RxSight, Inc.

RXST

34 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

6.67 USD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

13.65 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

1.88 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)